{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:06:49Z","timestamp":1793315209984,"version":"4.5.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,6]]},"DOI":"10.7759\/cureus.96246","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T21:23:38Z","timestamp":1762464218000},"source":"Crossref","is-referenced-by-count":2,"title":["Exploring the Effects of Pemivibart Monoclonal Antibody Infusion in Long COVID: A Case Series Offering Initial Clinical Insights"],"prefix":"10.7759","author":[{"given":"John M","family":"Baratta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla A","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Cobb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb2408466","article-title":"Long Covid defined","volume":"391","author":"Ely EW","year":"2024","unstructured":"Ely EW, Brown LM, Fineberg HV. Long Covid defined. N Engl J Med. 2024, 391:1746-53. 10.1056\/NEJMsb2408466","journal-title":"N Engl J Med"},{"key":"ref2","unstructured":"Long COVID - household pulse survey. (2025). Accessed. September 19, 2025: https:\/\/www.cdc.gov\/nchs\/covid19\/pulse\/long-covid.htm."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis HE","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023, 21:133-46. 10.1038\/s41579-022-00846-2","journal-title":"Nat Rev Microbiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03173-6","article-title":"Long COVID science, research and policy","volume":"30","author":"Al-Aly Z","year":"2024","unstructured":"Al-Aly Z, Davis H, McCorkell L, Soares L, Wulf-Hanson S, Iwasaki A, Topol EJ. Long COVID science, research and policy. Nat Med. 2024, 30:2148-64. 10.1038\/s41591-024-03173-6","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.698169","article-title":"Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms","volume":"12","author":"Proal AD","year":"2021","unstructured":"Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021, 12:2021.","journal-title":"Front Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.02.008","article-title":"Early clues regarding the pathogenesis of long-COVID","volume":"43","author":"Peluso MJ","year":"2022","unstructured":"Peluso MJ, Deeks SG. Early clues regarding the pathogenesis of long-COVID. Trends Immunol. 2022, 43:268-70. 10.1016\/j.it.2022.02.008","journal-title":"Trends Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac722","article-title":"Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae","volume":"76","author":"Swank Z","year":"2023","unstructured":"Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, Walt DR. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. 2023, 76:e487-90. 10.1093\/cid\/ciac722","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.04.037","article-title":"Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases","volume":"163","author":"Zollner A","year":"2022","unstructured":"Zollner A, Koch R, Jukic A, et al.. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022, 163:495-506.e8. 10.1053\/j.gastro.2022.04.037","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05542-y","article-title":"SARS-CoV-2 infection and persistence in the human body and brain at autopsy","volume":"612","author":"Stein SR","year":"2022","unstructured":"Stein SR, Ramelli SC, Grazioli A, et al.. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022, 612:758-63. 10.1038\/s41586-022-05542-y","journal-title":"Nature"},{"key":"ref10","unstructured":"INVIVYD. (2025). Accessed. September 19, 2025: https:\/\/pemgarda.com\/."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2023.09.051","article-title":"Remission of severe forms of long COVID following monoclonal antibody (MCA) infusions: a report of signal index cases and call for targeted research","volume":"75","author":"Scheppke KA","year":"2024","unstructured":"Scheppke KA, Pepe PE, Jui J, Crowe RP, Scheppke EK, Klimas NG, Marty AM. Remission of severe forms of long COVID following monoclonal antibody (MCA) infusions: a report of signal index cases and call for targeted research. Am J Emerg Med. 2024, 75:122-7. 10.1016\/j.ajem.2023.09.051","journal-title":"Am J Emerg Med"},{"key":"ref12","unstructured":"Effectiveness of treating post-COVID-19 CONDITIONS (Long COVID) with the SARS-CoV-2 specific monoclonal antibody, Sipavibart. (2025). Accessed. September 5, 2025: https:\/\/clinicaltrials.gov\/study\/NCT07021794."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.700782","article-title":"Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning","volume":"12","author":"Patterson BK","year":"2021","unstructured":"Patterson BK, Guevara-Coto J, Yogendra R, et al.. Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Front Immunol. 2021, 12:700782. 10.3389\/fimmu.2021.700782","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/421763-exploring-the-effects-of-pemivibart-monoclonal-antibody-infusion-in-long-covid-a-case-series-offering-initial-clinical-insights","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T21:23:39Z","timestamp":1762464219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/421763-exploring-the-effects-of-pemivibart-monoclonal-antibody-infusion-in-long-covid-a-case-series-offering-initial-clinical-insights"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.96246","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,6]]}}}